本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cidara Therapeutics, Inc.

217.71
+111.72105.41%
盘后217.20-0.5100-0.23%19:59 EST
成交量:1,728.90万
成交额:37.53亿
市值:68.45亿
市盈率:-21.32
高:218.85
开:217.20
低:216.80
收:105.99
52周最高:218.85
52周最低:13.90
股本:3,143.94万
流通股本:2,486.62万
量比:23.62
换手率:69.53%
股息:- -
股息率:- -
每股收益(TTM):-10.2103
每股收益(LYR):-26.7460
净资产收益率:-68.70%
总资产收益率:-29.35%
市净率:16.20
市盈率(LYR):-8.14

数据加载中...

2024/12/30

SEC问询函

Form CORRESP - Correspondence
2024/12/23

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/04

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/26

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/30

SEC问询函

Form CORRESP - Correspondence
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/26

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933